相关实验视频
Updated: Jul 13, 2025

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
206
目前对败血症和COVID-19中血小板缺血的知识
Junjie Cheng1, Hanhai Zeng2, Huaijun Chen2
1Intensive Care Unit, The Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China.
Frontiers in immunology
|October 16, 2023
概括
血小板数量低的血小板减少,发生在败血症和COVID-19中. 了解其免疫机制是开发治疗这些关键疾病的关键.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 血小板减少 (低血小板数) 是败血症和COVID-19中常见的一种并发症.
- 败血症的机制包括生产受损,加速破坏,封存和免疫反应.
- 在COVID-19中,与免疫相关的血小板缺血的机制尚不清楚.
研究的目的:
- 阐明COVID-19中血小板缺血的免疫相关机制.
- 为了比较败血症和COVID-19之间的血栓塞缩病原体.
- 在危急疾病中确定血小板缺血的潜在治疗点.
主要方法:
- 对毒症和COVID-19中血小板缺血的现有文献的审查.
- 对参与血小板数减少的免疫路径的分析.
- 疾病机制的比较研究.
主要成果:
- 败血症相关的血小板缺血涉及各种机制,如炎症和免疫破坏.
- COVID-19共享一些机制,但也呈现出独特的免疫相互作用,影响血小板.
- 针对血小板缺血的干预措施有望改善患者的治疗结果.
结论:
- 澄清COVID-19相关的血小板缺血的免疫机制是必不可少的.
- 向血小板缺血可能在败血症和COVID-19中提供治疗益处.
- 需要进一步的研究才能充分理解和治疗这种并发症.
相关概念视频
Blood Transfusion and Agglutination
10.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
20
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
20
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Acute Kidney Injury II: Pathophysiology
11
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
11
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Acute Kidney Injury III: Clinical Manifestations
13
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
13

